Rheumatology

Home » Industry News » Rheumatology

2022 April

Rheumatology real-world evidence studies are clinically important, but require careful interpretation

Real-world evidence studies such as a recent study by Fisher (1) examining the persistence of JAK1/3 inhibitor tofacitinib in patients with RA compared to the…

READ MORE

2022 April

Rheumatology real-world evidence studies are clinically important, but require careful interpretation

Real-world evidence studies such as a recent study by Fisher (1) examining the persistence of JAK1/3 inhibitor tofacitinib in patients with RA compared to the…

READ MORE